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The performance of different chemometric approaches was evaluated in the spectrophotometric de-
termination of pharmaceutical mixtures characterized by having the amount of components with a very
high ratio. Principal component regression (PCR), partial least squares with one dependent variable
(PLS1) or multi-dependent variables (PLS2), and multivariate curve resolution (MCR) were applied to the
spectral data of a ternary mixture containing paracetamol, sodium ascorbate and chlorpheniramine
(150:140:1, m/m/m), and a quaternary mixture containing paracetamol, caffeine, phenylephrine and
chlorpheniramine (125:6. 25:1.25:1, m/m/m/m). The UV spectra of the calibration samples in the range of
200–320 nm were pre-treated by removing noise and useless data, and the wavelength regions having
the most useful analytical information were selected using the regression coefﬁcients calculated in the
multivariate modeling. All the deﬁned chemometric models were validated on external sample sets and
then applied to commercial pharmaceutical formulations. Different data intervals, ﬁxed at 0.5, 1.0, and
2.0 point/nm, were tested to optimize the prediction ability of the models. The best results were obtained
using the PLS1calibration models and the quantiﬁcation of the species of a lower amount was sig-
niﬁcantly improved by adopting 0.5 data interval, which showed accuracy between 94.24% and 107.76%.
& 2015 Xi'an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Spectrophotometric analytical techniques are widely used in
the pharmaceuticals and food quality controls during the batch
production or stability controls. This choice is justiﬁed by the
simplicity of sample preparation and execution as well as by the
short analysis time and relatively lower cost than other analytical
techniques [1,2]. However, the techniques based on ordinary
spectrophotometry are affected by low resolution and are often
unsatisfactory in the analysis of complex mixtures [3–6]. Several
pharmaceuticals are multicomponent mixtures and often are dif-
ﬁcult to be analyzed because of overlapping signals or the pre-
sence of components in much lower concentration than the oth-
ers. In recent years, the advent of computerized instrumentation
coupled to multivariate analysis techniques has allowed to in-
crease the potential of the spectrophotometric analysis with the
ability to simultaneously process a large number of spectral data
recorded in turn by a high number of samples [7,8]. Analysis of
complex pharmaceutical mixtures by applying different chemo-
metric procedures on spectral data has been reported in manyon and hosting by Elsevier B.V. All
University.
).papers [9–13]. Multivariate curve resolution-alternating least
squares (MCR–ALS) has been applied to the study of complex
mixtures to resolve different components in pharmaceutical for-
mulation [14–19].
In building a calibration sample set, an appropriate design of
experiments (DOE) can affect the prediction ability of the multi-
variate models. In the present work, a simple latex design (SLD)
distributed on ﬁve concentration levels was applied in order to
select sets of reference mixtures covering the entire experimental
domain corresponding to the content of the commercial phar-
maceutical specialties [8]. Moreover, in the chemometric treat-
ment of complex data sets, it is usually preferable to reduce the
data in order to select those that carry useful analytical informa-
tion and at the same time minimize those that carry redundant or
useless information. In many cases, the choice of the most useful
data inﬂuences the predictive ability of the multivariate models
and this procedure can be very useful in the determination of the
components at very low concentration that are often hidden by
the more concentrated components [8].
In the ﬁrst step of a multivariate regression method, principal
component analysis (PCA) identiﬁes orthogonal directions of
maximum variance of the original data, and places the data in a
space of lower dimensionality made from the components that
have the highest variance. PCA combines the original variables intorights reserved. This is an open access article under the CC BY-NC-ND license
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ponents (PCs). The ﬁrst PCs are considered in the modeling be-
cause of containing the most useful information, whereas the last
ones can be discarded [20–23].
The principal component regression (PCR), partial least square 1
(PLS1), partial lest squares 2 (PLS2) and multivariate component
analysis (MCR) models were applied to two pharmaceutical formula-
tions, the ﬁrst one containing three active pharmaceutical ingredients
(APIs) and the other four APIs, which are very difﬁcult to be analyzed
by means of conventional spectrophotometric methods for the pre-
sence of some components in quantities much lower than the others.
The increase in the predictive power of the models was studied by
varying the instrumental parameter “data interval” between 0.5 and
2 nm in the recording of the spectra used in calibration.
The ternary formulation consisted of paracetamol (PAR), so-
dium ascorbate (ASC) and chlorpheniramine maleate (CHL), with a
ratio of 150:140:1 (m/m/m). The quaternary mixture contained
paracetamol (PAR), caffeine (CAF), phenylephrine hydrochloride
(PHE) and chlorpheniramine maleate (CHL) with a ratio of
125:6.25:1.25:1 (m/m/m/m). Both mixtures are commonly used as
analgesics and antipyretic specialties.
The analytical performance of the applied algorithms was tes-
ted on the data matrices from synthetic mixtures and commercial
pharmaceutical preparations.2. Materials and methods
2.1. Chemicals
The active pharmaceutical ingredients ASC (98%), CAF (99%),
CHL (99%), PAR (100%), and PHE (98%) were purchased from Sig-
ma-Aldrich (Milan, Italy) and used as received. The pharmaceutical
specialties Dequa-Flu
s
(Aspen Pharmacare SpA) and Zerinolﬂu
s
(Boehringer Ingelheim SpA) were obtained commercially. Pure
water and ethanol were of instrumental purity grade (J. T. Baker,
Holland). All other reagents were of the highest purity commer-
cially available.
2.2. Instruments
Absorption spectra were recorded on a Perkin-Elmer Lambda
40P spectrophotometer under the following conditions: quartz cell
10 mm; wavelength range 200–350 nm; scan rate 1 nm/s; time
response 1 s; spectral band 1 nm; data density 0.5, 1.0 and
2.0 point/nm. Spectral acquisition and elaboration were performed
by the software package UV Winlab 2.79.01 (Perkin-Elmer). Ap-
plication of PCR and PLS algorithms was supported by the software
package ‘The Unscrambler X 10.3’ (Camo Process As., Oslo, Nor-
way). MCR-ALS routines were performed under Matlab computer
environment and implemented as MATLAB functions. They were
used as described in previous works [24,25]. Source ﬁles con-
taining these algorithms are available on the website “www.
mcrals.info”.
2.3. Standard solutions
Stock solutions of the single compounds were prepared in
ethanol by dissolving nearly 20.0 mg of each drug in 100 mL ca-
librated ﬂasks. A calibration set of 18 ternary mixtures was pre-
pared with PAR concentration in the range of 5.05–30.3 mg/L, ASC
in the range of 2.04–30.60 mg/L and CHL in the range of 0.20–
5.05 mg/L. A second calibration set of 38 quaternary solutions was
prepared with the drugs in the following concentration ranges:
PAR 5.10–30.60 mg/L, CAF 0.50–5.00 mg/L, CHL 0.20–2.01 mg/L,
and PHE 0.21–2.10 mg/L.The calibration mixtures were prepared by adopting an SLD
distributed on ﬁve concentration levels. Two further independent
validation sets, comprising 15 ternary mixtures and 15 quaternary
mixtures, respectively, were then prepared to validate the cali-
bration models. Statistical analysis was performed on data from
analysis of three replicates for sample.
2.4. Pharmaceutical samples
Five tablets for each pharmaceutical specialty were reduced to
ﬁne powder and suspended in 100 mL of ethanol. The suspension
was sonicated for 10 min and then ﬁltered through a 45 μm
membrane ﬁlter. Samples for analysis were obtained after proper
dilution with ethanol.3. Chemometric elaboration
PCR and PLS are known as factor analysis methods. In the ﬁrst
step of calibration, concentrations and analytical signals from re-
ference samples are used to build a mathematical model. In the
following prediction step, this model is used to evaluate the con-
centration of an unknown sample.
PCR considers all spectral data simultaneously (X variables) and
correlates the concentration components (Y variables) with these
data in the second phase of multiple regression. On the other
hand, PLS modeling processes information from both spectral and
concentration data (X and Y) and projects information in the new
space of principal components.
In applying multivariate calibration to spectrophotometry, X
variables or descriptors are represented by the absorptivity values
of the samples at various wavelength values, whereas the Y vari-
ables or responses consisted of concentration values. In building
multivariate models, PCs have to reach the optimal number be-
cause the prediction error decreases with them until they reach an
optimal value. The most known validation procedure is full-cross
validation, in which one reference is removed from the calibration
set at a time and the same sample is predicted by using the cali-
bration built with the remaining references. The number of PCs
was chosen by adopting the root mean square error of cross vali-
dation (RMSECV), which estimates the error when unknown
samples are predicted with the calibration model. The best pre-
diction ability of the models corresponds to the lowest RMSECV.
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MCR–ALS provides the decomposition of the experimental data
matrix describing the chemical system into the contributions of
the single species as a bilinear relation between the concentra-
tions and the pure spectra, following the generalized law of
Lambert–Beer in multi-sample and multivariable version [11,12].
In matrix form, the bilinear model is expressed in the following
way:
D CS E 3T= + ( )
Table 1
Statistical parameters from full-cross validation of all the chemometric models for
ternary and quaternary mixtures in the range of 210–320 nm, data interval of 1 nm.
Model Analyte PCs RMSECV RE (%) r2 Slope Offset
PCR PAR 3 0.1842 1.17 0.9998 0.9988 0.0012
ASC 3 0.1953 6.43 0.9971 0.9752 0.0313
CHL 4 0.3488 56.30 0.7416 0.6458 0.0700
PAR 4 0.0733 0.7987 0.9999 0.9999 0.0031
CAF 4 0.1036 9.7120 0.9933 0.9623 0.0201
CHL 5 0.1602 32.1449 0.9207 0.8437 0.0371
PHE 5 0.2733 54.8336 0.7490 0.6105 0.0974
PLS1 PAR 3 0.4823 3.08 0.9988 1.0086 0.1246
ASC 3 0.2233 7.36 0.9961 0.9802 0.0391
CHL 4 0.0551 13.32 0.9853 0.9939 0.0035
PAR 4 0.0733 0.7980 0.9999 0.9980 0.0169
CAF 4 0.1078 10.1029 0.9927 0.9612 0.0224
CHL 5 0.1621 26.5193 0.9187 0.8467 0.0371
PHE 5 0.1130 25.7415 0.9173 0.7854 0.0453
PLS2 PAR 3 0.7184 4.5819 0.9971 0.9877 0.1237
ASC 3 0.4330 14.2579 0.9857 0.9330 0.1174
CHL 4 0.4506 72.7338 0.6012 0.5966 0.0961
PAR 4 0.0738 0.8039 0.9999 1.0000 0.0033
CAF 4 0.1078 10.1029 0.9927 0.9612 0.0224
CHL 5 0.1671 33.5223 0.9135 0.8264 0.0398
PHE 5 0.1694 33.9903 0.9125 0.8792 0.0452
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concentrations values of the different n species present in the
samples; ST is the spectra matrix; and E is the matrix associated to
the error. MCR–ALS algorithm is run by applying an iterative op-
timization procedure under a suitable set of constraints until es-
timation of C and ST matrices is given. This iteration procedure is
stopped when convergence is achieved by ﬁxing a preselected
number of cycles or when the value of lack of ﬁt (LOF) does not
change signiﬁcantly between consecutive iterations:
d d
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%LOF 100
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where dij and dij* are respectively the experimental and calculated
(by MCR–ALS) absorbance values. Another parameter used to in-
dicate the quality of MCR–ALS modeling results is the percentage
of explained variance (r2):
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4. Results and discussion
4.1. Spectrophotometric analysis and construction of the models
Absorption spectra for each calibration set were recorded in the
range of 200–350 nm by ﬁxing the value of data density at
1.0 point/nm. Fig. 1 shows the UV spectra of the single components
and their mixtures for both ternary and quaternary studied phar-
maceutical formulations. The mixtures contained the drugs with
the same ratio of the commercial specialties.
The determination of CHL in both formulations and PHE in the
quaternary formulation showed particular complexity because
their concentrations were very low compared to the concentra-
tions of the other components. The conventional spectro-
photometric methods appear difﬁculties in application as they use
only a limited number of wavelengths. In both mixtures, the
spectra of the individual compounds overlapped along the full
spectral range and no signal proportional to the components was
singled out. In contrast, the multivariate calibration methods,
which simultaneously use all the spectral data or at least a large
number, seemed more suitable for resolving these mixtures.
The wavelengths below 210 nm and over 320 nm were dis-
carded. The ﬁrst ones are usually affected by high variability that
can make the model unstable; the others were useless for theFig. 1. Full absorption spectra (data interval 1.0 point/nm) of the single components and
CHL 0.20 μg/mL. Quaternary mixtures (B): PAR 30.60 μg/mL, CAF 1.52 μg/mL, PHE 0.30 μabsence of signals due to the components. The 220–320 nm
spectral data were used to build the data matrices for the ternary
and quaternary samples, respectively. In the matrix of descriptors
(X), each reference was described by n variables, corresponding to
the absorbance values for all wavelengths; in the matrix of re-
sponse variables (Y), the samples were described by the con-
centrations of the drugs.
The algorithms, namely, PCR, PLS1, PLS2 and MCR, were applied
to these data matrices and the models carried out were validated
by full-cross validation. RMSECVs were re-calculated when a new
PC was added to the models every time. Table 1 summarizes the
optimal PCs and the corresponding statistical parameters.
RMSECV values could be considered satisfactory for most of the
components and all the models. In contrast, the values of r2 and RE
(%) were signiﬁcantly worse than those of the other components,
for CHL in the ternary mixture and for both CHL and PHE in the
quaternary mixture. The bad results for CHL and PHE could be
surely imputed to the relative low content of these drugs in the
respective mixtures. The number of PCs also showed the highest
values for CHL and PHE. As regards to the MCR method, the per-
centage value of LOF resulted in 7.92 and 42.21 for the ternary andtheir cumulative spectra. Ternary mixtures (A): PAR 25.25 μg/mL, ASC 23.46 μg/mL,
g/mL, CHL 0.25 μg/mL.
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However, the statistics indicated a preliminary substantial
equivalence between the multivariate techniques tested and none
of them showed a higher sensitivity than the others.
4.2. Analysis of prediction sets
The prediction ability of the models built was tested on a series
of ternary and quaternary synthetic mixtures. Two prediction sets
of 15 samples, containing the drugs in the same concentration
ranges used in the calibration sets, were randomly prepared. The
calibration models deﬁned above were applied to the prediction
samples and the accuracy and precision results were compared in
terms of percentage recovery and standard deviation. The results
of PAR and ASC quantiﬁcation by all the chemometric methods
were good, showing recovery within the range of 97.14%–103.27%
and cumulative standard deviation under 2.65. The high absor-
bance values of these drugs were surely essential in the success of
their determination. Determination of CAF, in the quaternaryFig. 2. Distribution of regression coefﬁcients for CHL in the ternary mixture (A),
CHL in the quaternary mixture (B) and PHE in the quaternary mixture (C). The
curve of the cumulative coefﬁcients B and the cutoff lines are also plotted.mixtures, gave good results too, despite of its relative low con-
centration (recovery 96.78%–102.58%; SDr3.10).
In contrast, less good results in terms of recovery (83.42%–
129.42%) and SD (r15.37) of CHL and PHE were conﬁrmed also in
this prediction step. An optimization procedure in the processing
of data was necessary to increase the prediction power of the
models for these drugs.
4.3. Optimization of the models
Two approaches were tried to optimize the models in order to
emphasize the spectral characteristics of the individual compo-
nents. The number of data interval was varied to provide a smaller
or greater number of data in the processing of algorithmic pat-
terns, and a recent procedure to select the wavelength regions
containing the most useful information for the single components
was applied.
Two additional series of spectra of the calibration samples were
recorded by ﬁxing the data interval at 0.5 and 2.0 nm, respectively.
The number of spectral data for each sample in the new matrices
thus passed from 120 to 240 and 60. The wavelength selection was
performed by a mathematical procedure recently proposed [8],
using the absolute values of the component regression coefﬁ-
cients. In a regression algorithm, the concentration of each com-
ponent is correlated with all the wavelengths through the fol-
lowing equation:
C b b b b 6i o n n1 1 2 2λ λ λ= + + + … + ( )
where Ci is the component concentration (analytical response), λ
the wavelengths (predictors), and b the regression coefﬁcients. b
values higher than 0.2 indicated wavelengths rich in useful in-
formation, while values below 0.1 indicated a negligible con-
tribution [26]. Along the full range of wavelengths, the absolute
values of b for each component were summed up to give a newTable 2
Statistical parameters from external validation of the models for ternary and qua-
ternary mixtures by adopting optimized wavelength ranges and 0.5 data interval.
Model Analyte PCs RMSEP RE (%) r2 Slope Offset
PCR PAR 3 0.7268 4.6353 0.9971 0.9871 0.1345
ASC 3 0.2414 3.2432 0.9961 0.9581 0.0154
CHL 3 0.0374 9.1643 0.9933 0.9881 0.0013
PAR 4 0.0725 0.7894 0.9999 1.0000 0.0012
CAF 4 0.1028 5.6284 0.9934 0.9826 0.0194
CHL 4 0.1036 20.7917 0.9876 0.9505 0.0140
PHE 4 0.1154 23.1650 0.9701 0.9397 0.0182
PLS1 PAR 3 0.3707 2.3643 0.9992 0.9969 0.0032
ASC 3 0.0907 2.9851 0.9994 0.9899 0.0015
CHL 3 0.0136 3.2816 0.9991 0.9937 0.0017
PAR 4 0.1942 2.1152 0.9996 0.9982 0.0023
CAF 4 0.0894 3.3802 0.9951 0.9752 0.0195
CHL 4 0.0589 4.8168 0.9897 0.9716 0.0026
PHE 4 0.0636 3.6352 0.9913 0.9885 0.0019
PLS2 PAR 3 0.7017 3.4754 0.9983 0.9944 0.0178
ASC 3 0.0894 2.9423 0.9994 0.9962 0.0012
CHL 3 0.0360 5.7047 0.9936 0.9914 0.0024
PAR 4 0.1707 1.8594 0.9997 0.9982 0.0007
CAF 4 0.1721 6.1228 0.9907 0.9817 0.0328
CHL 4 0.0739 5.8295 0.9840 0.9720 0.0132
PHE 4 0.0667 5.3928 0.9969 0.9869 0.0015
MCR PAR 3 0.6921 4.4141 0.9974 0.9940 0.0120
ASC 3 0.0844 3.7808 0.9984 0.9962 0.0013
CHL 3 0.0145 5.5077 0.9990 0.9928 0.0025
PAR 4 0.1598 1.7400 0.9998 0.9989 0.0076
CAF 4 0.1007 6.4332 0.9976 0.9655 0.0179
CHL 4 0.0607 8.1726 0.9921 0.9903 0.0029
PHE 4 0.0372 7.4667 0.9960 1.0021 0.0070
Table 3
Recovery (%) (7RSD) from application of optimized PCR, PLS and MCR–ALS models on the pharmaceutical formulations.
Zerinolﬂus Dequa-Flus
Model PAR ASC CHL PAR CAF PHE CHL
PCR 97.0173.25 99.0474.99 101.0072.21 103.0772.74 104.6474.77 96.8076.25 96.0075.28
PLS1 107.3772.23 98.9573.25 106.9375.32 101.9672.01 98.3273.25 105.7975.57 111.4676.21
PLS2 100.0673.60 101.0673.11 90.7474.25 94.2973.25 102.0275.21 94.5377.25 92.5278.96
MCR-ALS 98.8772.57 101.3875.25 106.1277.25 98.9374.35 96.1976.34 111.5778.22 102.0279.57
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After that, the average value of B of all components ( B¯) was
adopted as a cutoff value and the wavelengths presenting values of
B over the cutoff line were selected to build the new model [8].
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The spectral regions selected by this procedure were used for
the determination of PHE in the quaternary mixture and CHL in
both mixtures. Fig. 2 shows the distribution of the regression
coefﬁcients in the range of 210–320 nm for CHL in the ternary
mixture (A) and quaternary mixture (B) and for PHE in the qua-
ternary mixture (C). The wavelength ranges, selected by the pro-
cedure regression coefﬁcient which produced a better prediction
of CHL in the ternary mixtures without signiﬁcantly affecting the
prediction of the other components, were 222–252 nm and 289–
296 nm. For the analysis of the quaternary mixtures, the results
improved signiﬁcantly for both CHL and PHE by selecting the
ranges of 211–250 nm and 264–290 nm.
The regression models were re-built by adopting the selected
spectral data of the samples recorded at the various data intervals
(0.5–1.0–2.0 nm). There was a signiﬁcant decrease of PCs in these
new models, and especially in the models using a data interval of
0.5 nm. Both values of RMSECV and r2 were improved, demon-
strating such an increase in useful information from the adjust-
ment of this instrumental parameter. The new models were ap-
plied to assay the samples of the prediction sets, giving the results
summarized in Table 2.
The good values of RMSEP and r2, already reached for PAR, ASC
and CAF, were conﬁrmed and further improved, especially for CAF.
Recovery values were in the range of 96.21%–105.86% and preci-
sion was calculated within 3.14%–3.75% with no signiﬁcant dif-
ferences between the various models.
The dosage of CHL and PHE was greatly improved after opti-
mization, giving values of RMSEP signiﬁcantly lower than previous
ones. PLS1 proved the method mostly beneﬁting from the selec-
tion of spectral regions and data interval. Recovery was between
94.53% and 106.92% and SD not above 3, representing a remark-
able achievement considering the difﬁculties inherent to the two
analytical systems in the dosage of these components.
4.4. Analysis of commercial formulations
Commercial pharmaceutical specialties containing the studied
drugs were analyzed by using the ﬁnal chemometric models. The
assay results are summarized in Table 3. The experimental results
coincided with the values reported on the label of the
formulations.
Recovery values for PAR, ASC and CAF were in the range 94.29%
– 107.37% and precision was calculated within 2.01% – 6.34% for allthe methods. For the assay of CHL and PHE, application of the PLS1
models gave recovery between 105.79% and 111.46% and SD below
6.21.5. Conclusion
A comparative study on the application of the most known
chemometric techniques to the spectral data of complex phar-
maceutical formulations was performed. The PCR, PLS1, PLS2 and
MCR algorithms were applied to assay ternary and quaternary
mixtures of drugs characterized by a very high ratio in their con-
tent. Elaboration of the models was stressed by varying the value
of the instrumental data interval and selecting the most useful
wavelengths by means of a procedure based on the regression
coefﬁcients. The selection of the analytical information brought a
signiﬁcant advantage to the predictive power of all models.
However, the best assay results were obtained from the applica-
tion of PLS1 models to both the data matrices built with the
spectra at 0.5 nm1 data point. The satisfactory results showed
signiﬁcant contribution of the parameter data interval in improv-
ing the construction of multivariate models. Similarly, a suitable
selection of the spectral regions characteristics can greatly con-
tribute to the determination of the components that have low or
superimposed absorbance than that of other components.Acknowledgments
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